A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

RECRUITING

Columbia University - The Trustees of Columbia University in the City of New York, New York

RECRUITING

Montefiore Medical Center, New York

RECRUITING

Thomas Jefferson University Hospital, Philadelphia

RECRUITING

Emily Couric Clinical Cancer Center, Charlottesville

RECRUITING

Moffitt Cancer Center - McKinley Drive, Tampa

RECRUITING

MD Anderson Cancer Center, Houston

RECRUITING

Sarah Cannon Research Institute (SCRI), Denver

RECRUITING

Banner MD Anderson Cancer Center, Gilbert

RECRUITING

University of Arizona, Tucson

RECRUITING

John Wayne Cancer Institute (JWCI), Santa Monica

WITHDRAWN

Providence Portland Medical Center, Portland

RECRUITING

Oregon Health & Science University (3485 S. Bond), Portland

RECRUITING

Yale University Hospital, New Haven

RECRUITING

Massachusetts General Hospital, Boston

RECRUITING

NYU Langone Health Perlmutter Cancer Center, New York

RECRUITING

Lifespan Cancer Institute, Providence